- JB Chemicals & Pharmaceuticals will introduce medicated nicotine lozenges in May 2021 to help reduce the desire to consume or smoke tobacco.
- NFL Biosciences SA, a biopharmaceutical company developing botanical drugs for the treatment of addictions, will begin its CESTO II Phase II/III clinical trial in December 2021 to evaluate the efficacy and safety of its NFL-101 smoking cessation treatment
